September 30, 2019 Dataset Open Access

Harding, Rachel; Hutchinson, Ashley; Seitova, Alma; Arrowsmith, Cheryl; Edwards, Aled

BibTeX Export

@dataset{harding_rachel_2019_3555358,
  author       = {Harding, Rachel and
                  Hutchinson, Ashley and
                  Seitova, Alma and
                  Arrowsmith, Cheryl and
                  Edwards, Aled},
  title        = {{Large-scale purification of Q23 HTT from Sf9 
                   2019/09/30}},
  month        = sep,
  year         = 2019,
  note         = {{Dr. Harding is the recipient of the Huntington's 
                   Disease Society of America Berman Topper Career
                   Development Fellowship which funds and supports
                   this research, in addition to generous funding
                   from the CHDI Foundation and the Huntington
                   Society of Canada. The SGC is a registered charity
                   (number 1097737) that receives funds from AbbVie,
                   Bayer Pharma AG, Boehringer Ingelheim, Canada
                   Foundation for Innovation, Eshelman Institute for
                   Innovation, Genome Canada through Ontario Genomics
                   Institute [OGI-055], Innovative Medicines
                   Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766],
                   Janssen, Merck KGaA, Darmstadt, Germany, MSD,
                   Novartis Pharma AG, Ontario Ministry of Research,
                   Innovation and Science (MRIS), Pfizer, São Paulo
                   Research Foundation-FAPESP, Takeda, and Wellcome.}},
  publisher    = {Zenodo},
  doi          = {10.5281/zenodo.3555358},
  url          = {https://doi.org/10.5281/zenodo.3555358}
}